Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans

Journal of Addiction Medicine
Alex F ManiniYasmin L Hurd

Abstract

Cannabidiol (CBD) is hypothesized as a potential treatment for opioid addiction, with safety studies an important first step for medication development. We determined CBD safety and pharmacokinetics when administered concomitantly with a high-potency opioid in healthy subjects. This double-blind, placebo-controlled cross-over study of CBD, coadministered with intravenous fentanyl, was conducted at the Clinical Research Center in Mount Sinai Hospital, a tertiary care medical center in New York City. Participants were healthy volunteers aged 21 to 65 years with prior opioid exposure, regardless of the route. Blood samples were obtained before and after 400 or 800 mg of CBD pretreatment, followed by a single 0.5 (session 1) or 1.0 μg/kg (session 2) of intravenous fentanyl dose. The primary outcome was the Systematic Assessment for Treatment Emergent Events (SAFTEE) to assess safety and adverse effects. CBD peak plasma concentrations, time to reach peak plasma concentrations (tmax), and area under the curve (AUC) were measured. SAFTEE data were similar between groups without respiratory depression or cardiovascular complications during any test session. After low-dose CBD, tmax occurred at 3 and 1.5 hours in sessions 1 and 2, respe...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse·J P ZacnyH de Wit
Nov 1, 1991·Pharmacology, Biochemistry, and Behavior·P ConsroeK Schram
Jan 1, 1991·Therapeutic Drug Monitoring·P A Glare, T D Walsh
Jun 1, 1988·Journal of Personality and Social Psychology·D WatsonA Tellegen
Mar 30, 1981·Toxicology and Applied Pharmacology·H RosenkrantzR J Grant
May 2, 2001·Biochemical Pharmacology·M J Reid, L M Bornheim
Nov 27, 2002·European Journal of Pharmacology·Roger G PertweeAdèle Thomas
Oct 30, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·José Alexandre de Souza CrippaGeraldo Filho Busatto
Jan 13, 2006·Journal of Psychopharmacology·Antonio Waldo ZuardiJosé Alexandre S Crippa
Feb 21, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Markus KathmannEberhard Schlicker
Jul 11, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maria EllgrenYasmin L Hurd
Sep 22, 2006·Journal of Glaucoma·Ileana TomidaPhilip J Robson
Aug 23, 2007·Chemistry & Biodiversity·Raphael MechoulamLumír O Hanus
Jun 14, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ning QinChristopher M Flores
Jul 1, 2008·Biological Psychiatry·Stefan J BorgwardtPhilip K McGuire
Jul 2, 2008·Expert Review of Neurotherapeutics·Kirsten R Müller-Vahl, Hinderk M Emrich
Sep 20, 2008·Journal of Psychopharmacology·A W ZuardiV Tumas
Jan 7, 2009·Archives of General Psychiatry·Paolo Fusar-PoliPhilip K McGuire
Nov 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yanhua RenYasmin L Hurd
Sep 11, 2010·Journal of Psychopharmacology·José Alexandre S CrippaJaime Eduardo Cecílio Hallak
Apr 18, 2012·British Journal of Clinical Pharmacology·Paola MassiDaniela Parolaro
Oct 9, 2012·Journal of Psychopharmacology·Amir EnglundShitij Kapur
Mar 16, 2013·Analytical and Bioanalytical Chemistry·Mateus M BergamaschiMarilyn A Huestis

❮ Previous
Next ❯

Citations

Aug 14, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yasmin L HurdDidier Jutras-Aswad
Jun 1, 2017·Neuropharmacology·Matthew E SloanBernard Le Foll
May 31, 2018·Expert Opinion on Investigational Drugs·Dejana Ružić ZečevićSlobodan M Janković
Mar 1, 2016·Cannabis and Cannabinoid Research·István Ujváry, Lumír Hanuš
Apr 17, 2018·Fundamental & Clinical Pharmacology·Régis BouquiéPascale Jolliet
Feb 8, 2019·Journal of Clinical Pharmacology·C Michael White
Jan 19, 2018·Journal of Epilepsy Research·Emilio Perucca
Jun 13, 2019·Cold Spring Harbor Symposia on Quantitative Biology·Yishan Sun, Ricardo E Dolmetsch
Aug 23, 2019·Journal of Clinical Psychopharmacology·Yuli QianJohn S Markowitz
Jul 1, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Caroline Birer-WilliamsRichard D Boyce
Sep 2, 2017·Cannabis and Cannabinoid Research·Gerhard NahlerJosé A S Crippa
Dec 26, 2018·Medicines·Muhammad A Alsherbiny, Chun Guang Li
Dec 25, 2019·Cannabis and Cannabinoid Research·Karim S LadhaHance Clarke
Dec 12, 2018·Frontiers in Pharmacology·Sophie A MillarSaoirse E O'Sullivan
Nov 2, 2019·The American Journal of Psychiatry·David H Epstein
Sep 18, 2018·Cannabis and Cannabinoid Research·Beth Wiese, Adrianne R Wilson-Poe
Sep 2, 2017·Cannabis and Cannabinoid Research·Kerstin Iffland, Franjo Grotenhermen
Aug 29, 2020·BioMed Research International·Marta VázquezPaula Schaiquevich
Nov 27, 2020·International Journal of Molecular Sciences·Jakub MlostKatarzyna Starowicz
Nov 29, 2020·Epilepsy & Behavior : E&B·Birgitta MetternichKerstin A Klotz
Nov 23, 2020·Psychopharmacology·Stevie C BritchSharon L Walsh
Nov 17, 2020·Frontiers in Veterinary Science·Elizabeth M MorrisDavid L Harmon
Jan 31, 2021·Journal of General Internal Medicine·Premalatha BalachandranKevin P Hill
Apr 14, 2021·The Medical Journal of Australia·Chris Hayes, Jennifer H Martin
May 14, 2021·Journal of Pain Research·Jan M SchillingTobias Moeller-Bertram
Jun 1, 2021·Current Addiction Reports·Juliane MielauInge Mick
Jun 3, 2021·Cells·John Zewen Chan, Robin Elaine Duncan
Nov 30, 2021·Journal of Dietary Supplements·Paul ClaytonNathasha Bogoda
Sep 9, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shamema NasrinPhilip Lazarus
Sep 9, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shamema NasrinPhilip Lazarus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.